Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study
Zhang et al., Journal of Gastroenterology and Hepatology, doi:10.1111/jgh.15796
https://c19early.org/zhang5.html